Aller au contenu principal
Profil bibliographique

Weina Yang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

62Publications signalées
1699Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsTraditional Chinese Medicine AnalysisNeurological Disease Mechanisms and TreatmentsInflammation biomarkers and pathways

Les publications récentes

Accès ouvert 2026 article OpenAlex

Artificial intelligence-driven assessment of sarcopenia in orthopedic geriatrics: technical progress and clinical implications

Tengbo Pei, Yutian Lei, Yufang Gao, Minjie Zhang et autres

Sarcopenia, a progressive skeletal muscle disorder characterized by the loss of muscle mass and function, represents a significant challenge in geriatric orthopedics, with prevalence reaching as high as 48.7% in surgical populations. It is strongly associated with increased risks of falls, secondary …

cn (code pays fourni par la source)

1 citation Frontiers in Endocrinology
Accès ouvert 2025 article OpenAlex

Retrospective comparative study on efficacy and safety of different surgical procedures for pelvic organ prolapse

Yuquan Wang, Xi Guo, Weina Yang, Dong Liu et autres

The aim of this retrospective study was to analyze the efficacy and safety of lateral abdominal wall suspension during surgery compared with traditional procedures in patients with pelvic organ prolapse without uterine preservation. Collect the data of patients with uterine and vaginal …

cn (code pays fourni par la source)

1 citation Scientific Reports
Accès ouvert 2024 article OpenAlex

First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial

Weina Yang, Chengyuan Qian, Jiamin Luo, Chuan Chen et autres

• The possibility of immune checkpoint inhibitors combined with neoadjuvant chemoradiotherapy has been explored in multiple phase II clinical trials and reported promising pCR rates. However, severe immune-related toxicities have been a significant concern. Therefore, there is a pressing need for novel …

cn (code pays fourni par la source)

1 citation Translational Oncology
Accès ouvert 2024 article OpenAlex

Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study

Weina Yang, Xuemei Li, Chaofan Li, Chuan Chen et autres

Despite the emergence of various treatment strategies for rectal cancer based on neoadjuvant chemoradiotherapy, there is currently a lack of reliable biomarkers to determine which patients will respond well to neoadjuvant chemoradiotherapy. Through collecting hematological and biochemical parameters data of patients prior …

cn (code pays fourni par la source)

1 citation Cancer Investigation
Accès ouvert 2023 preprint OpenAlex

A novel neoadjuvant regimen of chemo-immuno-embolization with transcatheter rectal arterial intervention in locally advanced rectal cancer: a study protocol for a phase II trial (CIETAI-R)

Weina Yang, Chengyuan Qian, Mengxia Li, Chuan Chen et autres

Abstract Background Recent evidence suggests that patients with mismatch repair-deficient/microsatellite instability-high LARC are exceptionally sensitive to immune checkpoint inhibitors (ICIs), However, the majority of LARC patients are microsatellite-stable. Therefore, there is an urgent need to enhance the effectiveness of ICIs in this …

cn, pk (code pays fourni par la source)

0 citations Research Square

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.